Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Nausea in Patients on Naltrexone and Bupropion

Introduction to Nausea Management

  • The National Comprehensive Cancer Network recommends ondansetron 4 mg every 8 hours as needed as an appropriate and safe antiemetic choice for patients on naltrexone and bupropion, with the option to add scheduled prochlorperazine or metoclopramide if nausea persists beyond 2-3 days 1

Nausea Prevalence and Treatment

  • Nausea is a well-documented adverse effect of the naltrexone/bupropion combination, occurring in approximately 30-50% of patients taking this medication 2

Dosing and Escalation Strategies

  • The "as needed" approach for 2 days is appropriate initially, but if nausea persists beyond this timeframe, switching to scheduled dosing around-the-clock for one week before reassessing is recommended 1, 3
  • If ondansetron alone fails after 2-3 days, adding agents targeting different mechanisms, such as prochlorperazine 10 mg orally every 6 hours, rather than replacing ondansetron, is suggested 1, 3
  • Metoclopramide 10-20 mg orally three times daily provides both antiemetic and prokinetic effects, which may be particularly helpful if gastroparesis contributes to symptoms 1, 3

Monitoring and Reassessment

  • It is essential to rule out other causes of nausea, including constipation, electrolyte abnormalities, hyperglycemia, or GERD, before assuming the nausea is medication-related 1, 4
  • If nausea persists beyond one week despite multiple antiemetics, reassessing the underlying cause and considering whether continuing naltrexone/bupropion is appropriate given the modest weight loss benefit is necessary 1

REFERENCES

1

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

3

Nausea Management with Additional Medications [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Differential Diagnosis for Evening Nausea and Dry Heaving Unresponsive to Ondansetron [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025